Literature DB >> 7561532

Hemorrheologic effects of metabolites of pentoxifylline (Trental).

J L Ambrus1, S Stadler, M Kulaylat.   

Abstract

Pentoxifylline (Trental) is metabolized by red blood cells and the liver into seven metabolites. Metabolites I and V have significant hemorrheologic effects. They are both similar to pentoxifylline in their activity on red blood cell membrane fluidity. Metabolite I is more active than pentoxifylline in inhibiting ADP-induced platelet aggregation. Metabolite V is more active than pentoxifylline in inhibiting epinephrine-induced platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561532

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  3 in total

1.  A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans.

Authors:  Marie Magnusson; Ingar C Bergstrand; Sven Björkman; Anders Heijl; Bodil Roth; Peter Höglund
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

2.  Protective effect of pentoxifylline plus thalidomide against septic shock in mice.

Authors:  O Arrieta; A Ortiz-Reyes; D Rembao; M Calvillo; E Rivera; J Sotelo
Journal:  Int J Exp Pathol       Date:  1999-02       Impact factor: 1.925

3.  Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

Authors:  Ming Zhang; Yan-Jun Xu; Shushma A Mengi; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2004
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.